Shattuck Labs (STTK) Interest Expenses (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Interest Expenses of $106.7 million for Q4 2025, up 11.57% year-over-year from $95.6 million in Q4 2024, and up 26571.5% quarter-over-quarter from $400000.0 in Q3 2025.
Shattuck Labs (STTK) Interest Expenses (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Interest Expenses for 7 consecutive years, with $106.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Expenses rose 11.57% year-over-year to $106.7 million; the TTM figure through Mar 2026 stood at -$200000.0 (changed N/A YoY), while the FY2025 annual figure was $106.7 million, up 11.57% from the prior year.
- Interest Expenses rose to $106.7 million in Q4 2025 per STTK's latest filing, from $400000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $106.7 million in Q4 2025 and bottomed at -$200000.0 in Q4 2022.
- Historically, Interest Expenses has averaged $21.6 million across 5 years, with a median of $6.4 million in 2022.
- Annual changes were most pronounced in 2022 — Interest Expenses slumped 100.66% — and 2023, when it soared 38293.0%.
- Shattuck Labs' Interest Expenses stood at $30.3 million in 2021, then tumbled by 100.66% to -$200000.0 in 2022, then jumped by 38293.0% to $76.4 million in 2023, then grew by 25.18% to $95.6 million in 2024, then increased by 11.57% to $106.7 million in 2025.
- Business Quant data shows STTK's Interest Expenses at $106.7 million in Q4 2025, $400000.0 in Q3 2025, and $100000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 15.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.00 Mn |
| Jun 30, 2026 | 15.00 Mn |
| Dec 31, 2025 | 106.69 Mn |
| Dec 31, 2025 | 106.69 Mn |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Dec 31, 2024 | 95.62 Mn |
| Dec 31, 2024 | 95.62 Mn |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 12.40 Mn |
| Mar 31, 2024 | 12.40 Mn |
| Dec 31, 2023 | 76.39 Mn |
| Dec 31, 2023 | 76.39 Mn |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |